198 related articles for article (PubMed ID: 36485079)
1. Diagnostic pitfalls and conundrums in type 1 von Willebrand disease.
Sidonio RF; Lavin M
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):618-623. PubMed ID: 36485079
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of slightly reduced von Willebrand factor activity.
Bykowska K; Ceglarek B
Pol Arch Intern Med; 2020 Mar; 130(3):225-231. PubMed ID: 31990275
[TBL] [Abstract][Full Text] [Related]
3. CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.
Sanders YV; van der Bom JG; Isaacs A; Cnossen MH; de Maat MP; Laros-van Gorkom BA; Fijnvandraat K; Meijer K; van Duijn CM; Mauser-Bunschoten EP; Eikenboom J; Leebeek FW;
J Thromb Haemost; 2015 Jun; 13(6):956-66. PubMed ID: 25832887
[TBL] [Abstract][Full Text] [Related]
4. Quantitative impact of using different criteria for the laboratory diagnosis of type 1 von Willebrand disease.
Quiroga T; Goycoolea M; Belmont S; Panes O; Aranda E; Zúñiga P; Pereira J; Mezzano D
J Thromb Haemost; 2014 Aug; 12(8):1238-43. PubMed ID: 24796601
[TBL] [Abstract][Full Text] [Related]
5. Von Willebrand Factor (VWF) multiplex activity assay differentiation of type 1 von Willebrand Disease (VWD) and variant VWD.
Roberts JC; Christopherson PA; Tarantino MD; Gonzales SE; Morateck PA; Perry CL; Flood VH; Abshire TC; Montgomery RR;
Haemophilia; 2024 Jan; 30(1):161-168. PubMed ID: 38013388
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding score.
Lavin M; Christopherson P; Grabell J; Abshire T; Flood V; Haberichter SL; Lillicrap D; O'Donnell JS; Montgomery RR; James PD
J Thromb Haemost; 2022 Oct; 20(10):2246-2254. PubMed ID: 35780487
[TBL] [Abstract][Full Text] [Related]
7. Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.
Batsuli G; Zimowski KL; Carroll R; White MH; Woods GM; Meeks SL; Sidonio RF
J Cardiothorac Vasc Anesth; 2022 Mar; 36(3):724-727. PubMed ID: 33618961
[TBL] [Abstract][Full Text] [Related]
8. The role of genetics in the pathogenesis and diagnosis of type 1 Von Willebrand disease.
Flood VH; Garcia J; Haberichter SL
Curr Opin Hematol; 2019 Sep; 26(5):331-335. PubMed ID: 31261173
[TBL] [Abstract][Full Text] [Related]
9. Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.
Flood VH; Christopherson PA; Gill JC; Friedman KD; Haberichter SL; Bellissimo DB; Udani RA; Dasgupta M; Hoffmann RG; Ragni MV; Shapiro AD; Lusher JM; Lentz SR; Abshire TC; Leissinger C; Hoots WK; Manco-Johnson MJ; Gruppo RA; Boggio LN; Montgomery KT; Goodeve AC; James PD; Lillicrap D; Peake IR; Montgomery RR
Blood; 2016 May; 127(20):2481-8. PubMed ID: 26862110
[TBL] [Abstract][Full Text] [Related]
10. Von Willebrand's disease: case report and review of literature.
Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
[TBL] [Abstract][Full Text] [Related]
11. von Willebrand disease and aging: an evolving phenotype.
Sanders YV; Giezenaar MA; Laros-van Gorkom BA; Meijer K; van der Bom JG; Cnossen MH; Nijziel MR; Ypma PF; Fijnvandraat K; Eikenboom J; Mauser-Bunschoten EP; Leebeek FW;
J Thromb Haemost; 2014 Jul; 12(7):1066-75. PubMed ID: 24750783
[TBL] [Abstract][Full Text] [Related]
12. von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis.
Kalot MA; Husainat N; El Alayli A; Abughanimeh O; Diab O; Tayiem S; Madoukh B; Dimassi AB; Qureini A; Ameer B; Eikenboom JCJ; Giraud N; McLintock C; McRae S; Montgomery RR; O'Donnell JS; Scappe N; Sidonio RF; Brignardello-Petersen R; Flood VH; Connell NT; James PD; Mustafa RA
Blood Adv; 2022 Jan; 6(1):62-71. PubMed ID: 34610118
[TBL] [Abstract][Full Text] [Related]
13. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
14. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
15. The necessity of repeat testing for von Willebrand disease in adult patients with mild to moderate bleeding disorders.
Mehic D; Kraemmer D; Tolios A; Bücheler J; Quehenberger P; Haslacher H; Ay C; Pabinger I; Gebhart J
J Thromb Haemost; 2024 Jan; 22(1):101-111. PubMed ID: 37741511
[TBL] [Abstract][Full Text] [Related]
16. Type 1 von Willebrand Disease in a Pediatric Patient Caused by a Novel Heterozygous Deletion of Exons 1 to 6 of the von Willebrand Factor Gene: A Case Report.
Lapić I; Radić Antolic M; Rogić D; Dejanović Bekić S; Coen Herak D; Bilić E; Zadro R
Lab Med; 2023 Jul; 54(4):434-438. PubMed ID: 36468906
[TBL] [Abstract][Full Text] [Related]
17. Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease.
de Wee EM; Sanders YV; Mauser-Bunschoten EP; van der Bom JG; Degenaar-Dujardin ME; Eikenboom J; de Goede-Bolder A; Laros-van Gorkom BA; Meijer K; Hamulyák K; Nijziel MR; Fijnvandraat K; Leebeek FW;
Thromb Haemost; 2012 Oct; 108(4):683-92. PubMed ID: 22918553
[TBL] [Abstract][Full Text] [Related]
18. New advances in the diagnosis of von Willebrand disease.
Sharma R; Haberichter SL
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):596-600. PubMed ID: 31808831
[TBL] [Abstract][Full Text] [Related]
19. Controversies in the diagnosis of Type 1 von Willebrand disease.
Bowman ML; James PD
Int J Lab Hematol; 2017 May; 39 Suppl 1():61-68. PubMed ID: 28447419
[TBL] [Abstract][Full Text] [Related]
20. Evaluating Performance of Contemporary and Historical von Willebrand Factor (VWF) Assays in the Laboratory Identification of von Willebrand Disease (VWD): The Australasian Experience.
Favaloro EJ; Dean E; Arunachalam S
Semin Thromb Hemost; 2022 Sep; 48(6):711-731. PubMed ID: 35803263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
